Sponsored Links
| Ironwood And Forest Announce Positive Linaclotide Results From Two Pivotal Phase 3 Trials In Patients With Chronic Constipation |
 |
 |
 |
| Medical News - Irritable-Bowel Syndrome | |||
|
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational drug linaclotide in patients with chronic constipation (CC)... Read more: Irritable-Bowel Syndrome News From Medical News Today
|